Anti-Siglec-2 / CD22 (NCI m972)

Anti-Siglec-2 / CD22 (NCI m972) is a humanized monoclonal antibody targeting CD22, a Siglec family lectin present on B cells. It is a promising novel therapeutics for B-cell acute lymphoblastic leukemia (BCP-ALL). MW :144.3 KD.
Supplier Selleck Chemicals
Product # A3058
Sku # A3058-1mg
Pricing 1mg, $539.00
Feedback